Your search history is turned on.
Date: April 8, 2011 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
Microsoft Word - ambf0408 DM_MTL/119918-00018/2285849.1 ATTENTIONDIRECTEURSDESRUBRIQUES AFFAIRES/FINANCE/SANT AMBRILIABIOPHARMAANNONCEQUELLEDEMANDERALAPERMISSIONDEMETTREFINSA PROTECTIONENVERTUDELALACCETDPOSERA UNEDEMANDEDEFAILLITE Montral, Qubec (Marketwire Le 8 avril 2011) Ambrilia annonce que se...
Microsoft Word - amba0408 ATTENTION BUSINESS/FINANCIAL/HEALTH EDITORS AMBRILIA BIOPHARMA ANNOUNCES THAT IT WILL SEEK PERMISSION TO TERMINATE CCAA PROTECTION AND FILE FOR BANKRUPTCY Montreal, Quebec (Marketwire April 8, 2011) Ambrilia announces that its Directors have approved resolutions whereby the Corporation will seek permission to terminate the ...
DCLARATION DE CHANGEMENT IMPORTANT DCLARATION DE CHANGEMENT IMPORTANT FORMULAIRE 51-102F3 Rubrique 1. metteur assujetti Ambrilia Biopharma inc. 1010, rue Sherbrooke ouest, Bureau 1800 Montral (Qubec) H3A 2R7 ( Ambrilia ) Rubrique 2. Date du changement important Le 7 avril 2011 Rubrique 3. C...
MATERIAL CHANGE REPORT MATERIAL CHANGE REPORT FORM 51-102F3 Item 1. Reporting Issuer Ambrilia Biopharma Inc. 1010 Sherbrooke Street West, Suite 1800 Montral, Qubec H3A 2R7 (Ambrilia) Item 2. Date of Material Change April 7, 2011 Item 3. Press Release A press release describing the materi...
Date: March 30, 2011 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
ATTENTION BUSINESS/FINANCIAL/HEALTH EDITORS ATTENTION DIRECTEURS DES RUBRIQUES AFFAIRES/FINANCE/SANT AMBRILIA BIOPHARMA DPOSE SON RAPPORT BI-HEBDOMADAIRE SUR LA SITUATION Montral (Qubec) (Marketwire Le 30 mars 2011) Ambrilia Biopharma inc. (TSX : AMB) met aujourdhui son rapport bi-hebdom...
ATTENTION BUSINESS/FINANCIAL/HEALTH EDITORS ATTENTION BUSINESS/FINANCIAL/HEALTH EDITORS AMBRILIA BIOPHARMA PROVIDES BI-WEEKLY UPDATE ON ITS STATUS Montreal, Quebec (Marketwire March 30, 2011) Ambrilia Biopharma Inc. (TSX:AMB) is providing today its bi-weekly Default Status Report under National Policy...
Date: March 29, 2011 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
DCLARATION DE CHANGEMENT IMPORTANT DCLARATION DE CHANGEMENT IMPORTANT FORMULAIRE 51-102F3 Rubrique 1. metteur assujetti Ambrilia Biopharma inc. 1010, rue Sherbrooke ouest, Bureau 1800 Montral (Qubec) H3A 2R7 ( Ambrilia ) Rubrique 2. Date des changements importants Le 17 mars 2011 Rubrique 3....
MATERIAL CHANGE REPORT MATERIAL CHANGE REPORT FORM 51-102F3 Item 1. Reporting Issuer Ambrilia Biopharma Inc. 1010 Sherbrooke Street West, Suite 1800 Montral, Qubec H3A 2R7 (Ambrilia) Item 2. Date of Material Changes March 17, 2011 Item 3. Press Release Two press releases describing the m...
Date: March 17, 2011 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
Microsoft Word - Ambrilia_Press_Release_-_Mar 17_2011_2_.doc ATTENTION BUSINESS/FINANCIAL/HEALTH EDITORS AMBRILIA BIOPHARMA ANNOUNCES APPROVAL OF LICENSING OF MTX AND OSK-1 AND OF AN OPTION AGREEMENT FOR PSP-94 Montreal, Quebec (Marketwire March 17, 2011) Ambrilia announces that it has entered into a Heads of Agreement with ZBx Corporation (``Option`...
Microsoft Word - Press_Release__FRENCH__-_Mar 17 2011_2_.doc DM_MTL/119918-00018/2285849.1 ATTENTION DIRECTEURS DES RUBRIQUES AFFAIRES/FINANCE/SANT AMBRILIA BIOPHARMA ANNONCE LAPPROBATION DE SON ENTENTE DE LICENCE POUR MTX ET OSK-1 ET DUNE OPTION PORTANT SUR LE PSP-94 Montral, Qubec (Marketwire Le 17 mars 2011) Ambrilia annonce quelle a...